The DMPtNPS@cGAMP + RT group exhibited an increase in C‐X‐C motif chemokine ligand 10 (CXCL10), which is accountable for the recruitment of CXCR3+ T cells to the tumor site as well as being a marker of activated CD8+T cells.[39] This increase was not observed in the other treatment groups. This evidence concerns the gene CD8A and neoplasm.